OVER DEZE AFLEVERING
4basebio PLC (AIM:4BB, FRA:8L7, ETR:88Q) CEO Amy Walker joined Proactive's Stephen Gunnion to discuss the company's synthetic DNA platform, growing commercial momentum and key milestones for investors.
Walker explained how 4basebio's enzyme-based technology provides a cleaner, faster and more cost-effective alternative to conventional plasmid DNA manufacturing, supporting applications in cell and gene therapy, vaccines and gene editing. She also highlighted the launch of the company's single-stranded DNA product, which offers lower toxicity and the ability to produce longer DNA molecules for advanced gene editing.
The interview also covers a recent Phase 2 clinical supply agreement, the appointment of mRNA expert Jeff Coller to the Strategic Advisory Board, expansion of the company's Cambridge manufacturing facility and the commercial milestones investors should watch for over the coming months.
For more interviews and market insights, visit Proactive's YouTube channel. Don't forget to like this video, subscribe to the channel and enable notifications so you never miss future content.
#4basebio #SyntheticDNA #DNAManufacturing #GeneEditing #CRISPR #CellTherapy #GeneTherapy #Biotech #Biotechnology #LifeSciences #mRNA #Vaccines #PersonalizedMedicine #CancerVaccines #HealthcareInnovation #ClinicalTrials #CambridgeBiotech #Investing #SmallCapStocks #ProactiveInvestors
Walker explained how 4basebio's enzyme-based technology provides a cleaner, faster and more cost-effective alternative to conventional plasmid DNA manufacturing, supporting applications in cell and gene therapy, vaccines and gene editing. She also highlighted the launch of the company's single-stranded DNA product, which offers lower toxicity and the ability to produce longer DNA molecules for advanced gene editing.
The interview also covers a recent Phase 2 clinical supply agreement, the appointment of mRNA expert Jeff Coller to the Strategic Advisory Board, expansion of the company's Cambridge manufacturing facility and the commercial milestones investors should watch for over the coming months.
For more interviews and market insights, visit Proactive's YouTube channel. Don't forget to like this video, subscribe to the channel and enable notifications so you never miss future content.
#4basebio #SyntheticDNA #DNAManufacturing #GeneEditing #CRISPR #CellTherapy #GeneTherapy #Biotech #Biotechnology #LifeSciences #mRNA #Vaccines #PersonalizedMedicine #CancerVaccines #HealthcareInnovation #ClinicalTrials #CambridgeBiotech #Investing #SmallCapStocks #ProactiveInvestors
Engels
Verenigde Staten
TRANSCRIPTIE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OUDE AFLEVERINGEN ZOEKEN
Zoek naar eerdere afleveringen van Proactive - Interviews for investors.
ANDERE AFLEVERINGEN IN DEZE PODCAST
S&U PLC (LSE:SUS) chairman Anthony Coombs spoke with Proactive's Stephen Gunnion about the group’s new £600 million funding facilities, which replace £330 million of existing arrangements at improved rates and support its next phase of growth.
Coombs described the deal as transformational, giv…
OTC Markets Group Head of APAC, International Corporate Services Stephen Shipley talked with Proactive about the company’s strategy for expanding its presence across the Asia-Pacific region and helping international companies improve access to US investors.
Speaking from Sydney during IMARC, Shipl…
Midnight Sun Mining Corp Vice President of Business Development Adrian O’Brien joined Steve Darling from Proactive to provide an update on ongoing drilling at the company’s Dumbwa copper deposit in Zambia, where recent results are pointing to a significant expansion of the mineralized system in the…
Hive Digital Technologies Executive Chairman Frank Holmes Steve Darling from Proactive to discuss a major financing agreement for the company’s subsidiary, BUZZ High Performance Computing (BUZZ HPC), which has secured an approximately $129 million credit facility to fund advanced AI computing infra…
Cascade Copper CEO Jeff Ackert joined Steve Darling from Proactive to discuss recent drilling results at the company’s Centerfire project in Ontario, plans for a second phase of exploration and preparations for drilling at the Copper Plateau project in British Columbia.
Ackert explained that Casca…
Disclaimer: De podcast en de illustraties die op deze pagina zijn ingesloten, zijn afkomstig van Proactive, eigendom van de eigenaar en niet gelieerd aan of goedgekeurd door Listen Notes, Inc.
BEWERKEN
Bedankt voor uw hulp bij het up-to-date te houden van de podcast-database .
